Diversified Healthcare Trust: A Cautious Buy
Diversified Healthcare Trust is rated 'Buy' as fundamentals and balance sheet have improved despite recent share price gains. Q2 2026 saw SHOP NOI up 37.2% YoY and margin expansion, with normalized FFO surging 109.4% to $0.16/share. DHC's deleveraging is notable: net debt to adjusted EBITDAre fell to 7.1x, with no major maturities until 2028 and $270M in liquidity.